19 - 21 October 2021
Thanks for joining us for the 2020 Interactive Response Technologies.
Check back soon for more information on the 2021 event!
The 2020 Virtual Event
With the shift to a virtual format we have worked hard to put you first. Expect a program that works around you with a thoroughly researched agenda spread across three days. Sessions will be manageable and have the option of on-demand access* so, whether you wish to attend in a traditional format and connect with your peers during the live discussions or log in at a later date, the virtual experience is truly unique to you and your schedule.
You can expect access to enhanced networking opportunities, interactive Q&A sessions, and an all-round socially engaged digital experience.
*Excluding sessions limited to live viewings only. Subject to speaker permissions.
One Platform for a Seamless Experience
One Platform for a Seamless Experience
Access to Interactive Response Technologies's content, networking and on-demand sessions will be available in one place, at the touch of a button.
In-depth Expert Insights
In-depth Expert Insights
You will now have access to the same thoroughly-researched agenda both during the live sessions and on-demand.
Novel Networking Opportunities
Novel Networking Opportunities
Discover how Interactive Response Technologies will elevate your conference networking experience. With AI-matchmaking, dedicated networking breaks and 24/7 access, it's never been easier to connect with who matters to you.
THE 2020 EXPERIENCE: IS YOUR INTERACTIVE RESPONSE TECHNOLOGY EVOLVING?
Put your IRT questions to expert panels:
Put your IRT questions to expert panels:
- Data and IRT: What does senior leadership want vs. what IRT can provide?
- The impact of COVID-19: Industry experts divulge their business continuity strategy.
- IRT outsourcing vs. in-sourcing: What are the pros and cons of each?
- Design thinking for IRT from the vendor perspective: IRT 2.0, the optimal model, meeting standards.
Case studies: How does your strategy measure up?
Case studies: How does your strategy measure up?
- Amgen reveal their innovative supplier selection process including an in-depth questionnaire, dummy version of a protocol and final selection.
- Side-by-side comparison: Dive into insights from Biogen and Pfizer on their outsourced and in-sourced approaches.
- Direct-to-patient and virtual clinical trials. Find the best fit, address patient privacy, and the impact on supply chain.
Develop and refine your IRT strategy with practical guidance:
Develop and refine your IRT strategy with practical guidance:
- Looking for fundamentals? A deep-dive into the standards and oversight guidelines, forecasting strategies and seamless data integration.
- A seasoned IRT professional? Join in-depth discussions on partnering and relationship management, systems integration, accountability and reconciliation. Plus, take part in a collaborative think-tank, sharing insights on the topics most important to you.
IRT, IVRS, RTSM. No matter what you call it, we can help.
The emergence of Direct-to-Patient trials
The emergence of Direct-to-Patient trials
Dedicated discussions to get you on track with the role of IRT within direct-to-patient trials. Learn more about the challenges manufacturers are facing within these clinical trials, from patient blinding to other logistical challenges, and how to successfully overcome them.
Novel technologies
Novel technologies
The introduction of mobile technologies and apps have resulted in new challenges for the industry, so what strategies are your clinical peers developing? Discover the new generation of IRT to support Phase I trials, natural language processing to read protocols and configuring systems' functionality.
e-Clinical trial solutions market
e-Clinical trial solutions market
Join the key players in this growing market this October! An opportunity to put your questions to those paving the way towards the future of e-clinical trials. And, your chance to obtain direct insights into their technologies such as IRT/CTMS, eCOA/ePRO, EDC and CTMS.
Regulatory Perspective and Guidelines
Regulatory Perspective and Guidelines
Review regulatory expectations from the FDA and MHRA on how they are looking more closely at audit trail and data integrity in the IRT system.